Citations

Showing 10 of 108119 citations.

Implication of Adult Hippocampal Neurogenesis in Alzheimer’s Disease and Potential Therapeutic Approaches
Essa, Hesham, Peyton, Lee, Hasan, Whidul , León, Brandon Emanuel, Choi, Doo-Sup, Peyton, Lee , Essa, Hesham , Hasan, Whidul , León, Brandon Emanuel, Choi, Doo-Sup

Mayo Clinic

Cells | January 16, 2022 | Volume: 11 | Issue: 2 | Pages: 286

10.3390/cells11020286 | PMID 35053402 Get It

Alzheimer’s disease is the most common neurodegenerative disease, affecting more than 6 million US citizens and representing the most prevalent cause for dementia. Neurogenesis has been repeatedly reported to be impaired in AD mouse models, but the reason for this impairment remains unclear. Several key factors play a crucial role in AD including Aβ accumulation, intracellular neurofibrillary tangles accumulation, and neuronal loss (specifically in the dentate gyrus of the hippocampus). Neurofibrillary tangles have been long associated with the neuronal loss in the dentate gyrus. Of note, Aβ accumulation plays an important role in the impairment of neurogenesis, but recent studies started to shed a light on the role of APP gene expression on the neurogenesis process. In this review, we will discuss the recent approaches to neurogenesis in Alzheimer disease and update the development of therapeutic methods.
How to manage traumatic brain injury without invasive monitoring?
Godoy, Daniel A., Rabinstein, Alejandro A., Godoy, Daniel A., Rabinstein, Alejandro A.

Mayo Clinic

Current Opinion in Critical Care | January 16, 2022 | Volume: 28 | Issue: 2 | Pages: 111-122

10.1097/mcc.0000000000000914 | PMID 35034077 Get It

Purpose of review Severe traumatic brain injury (TBI) is an extremely serious health problem, especially in low–middle income countries (LMICs). The prevalence of severe TBI continues to increase in LMICs. Major limitations in the chain of care for TBI patients are common in LMICs including suboptimal or nonexistent prehospital care, overburdened emergency services, lack of trained human resources and limited availability of ICUs. Basic neuromonitoring, such as intracranial pressure, are unavailable or underutilized and advanced techniques are not available. Recent findings Attention to fundamental principles of TBI care in LMICs, including early categorization, prevention and treatment of secondary insults, use of low-cost technology for evaluation of intracranial bleeding and neuromonitoring, and emphasis on education of human resources and multidisciplinary work, are particularly important in LMICs. Institutional collaborations between high-income and LMICs have developed evidence focused on available resources. Accordingly, an expert group have proposed consensus recommendations for centers without availability of invasive brain monitoring. Summary Severe TBI is very prevalent in LMIC and neuromonitoring is often not available in these environments. When intracranial pressure monitors are not available, careful attention to changes on clinical examination, serial imaging and noninvasive monitoring techniques can help recognize intracranial hypertension and effectively guide treatment decisions.
Validated 5 – Point photonumeric scales for the assessment of hand atrophy
Pavicic, Tatjana , Pooth, Rainer, Prinz, Valentina, Cajkovsky, Mia, Hernandez, Claudia A, Mueller, Daniel S., Sattler, Sonja , Klepetko, Heike , Kerscher, Martina , Fabi, Sabrina G. , Frank, Konstantin , Day, Doris , Cotofana, Sebastian , Frank, Konstantin , Green, Jeremy B. , Mueller, Daniel S., Suwanchinda, Atchima , Cotofana, Sebastian

Mayo Clinic

Journal of Cosmetic Dermatology | January 16, 2022 | Volume: 21 | Issue: 3 | Pages: 933-939

10.1111/jocd.14776 | PMID 35034418 Get It

AbstractObjectiveQuantifying the degree of dorsal hand atrophy is a challenging endeavor, but often necessary, in both the clinical and the research setting. The aim of this investigation was to create and consecutively validate a 5‐point photonumeric scale for assessment of dorsal hand atrophy.Material and MethodsA medical team created a novel 5‐point photonumeric scale. Twelve international raters were involved in the digital validation, while five raters performed a live validation.ResultsFor the digital validation of the Croma Hand Atrophy Assessment Scale, a total of 72 subjects (58 females, 14 males) with a mean age of 43.0 ± 14.4 years [18–73 years] were assessed. For the live validation, 88 subjects (73 females, 15 males) with a mean age of 45.0 ± 14.1 years [20–73 years] were rated. The results revealed almost perfect intra‐rater (ICC: 0.90 [95% CI: 0.88–0.92]) and inter‐rater agreements (ICC: 0.85 [95% CI: 0.81–0.89] and 0.86 [95% CI:0.82–0.89]) in the digital validation and substantial intra‐rater (ICC: 0.79 [95% CI: 0.75–0.82]) and inter‐rater agreements (ICC: 0.75 [95% CI: 0.68–0.81] and ICC: 0.67 [95% CI: 0.54–0.77]) in the live validation.ConclusionThe created scale to assess dorsal hand atrophy has been shown to provide substantial‐to‐almost perfect agreement in the digital and live validation cycles and reached comparable intra‐rater and inter‐rater agreement to already published and validated scales. It is expected that the created scale will help physicians and researchers in the assessment of hand atrophy in the clinical and research setting in the future.
Pazopanib in Patients with Osteosarcoma Metastatic to the Lung: Phase 2 Study Results and the Lessons for Tumor Measurement
Frankel, Paul , Ruel, Chris , Uche, An, Choy, Edwin , Okuno, Scott H. , Somiah, Neeta, Chow, Warren , Ruel, Christopher , Okuno, Scott , Somaiah, Neeta , Chow, Warren A , Choy, Edwin

Mayo Clinic

Journal of Oncology | January 16, 2022 | Volume: 2022 | Issue: No issue available | Pages: 1-9

10.1155/2022/3691025 | PMID 35075361 Get It

Background. This single-arm, multicenter, phase 2 study evaluated the safety and antitumor activity of pazopanib in patients with unresectable, pulmonary metastatic osteosarcoma. Patients and Methods. Patients with pulmonary metastatic osteosarcoma unresponsive to chemotherapy were eligible. Patients who received prior tyrosine kinase inhibitor therapy were excluded. Pazopanib at 800 mg once daily was administered for 28-day cycles. Tumor responses were evaluated by local radiology assessment 1 month prior to and after initiation of treatment to calculate tumor doubling time and after every even numbered cycle. The primary endpoints were progression-free survival at 4 months, concomitant with a demonstrated 30% increase in tumor doubling time relative to the pretreatment growth rate. Results. 12 patients (7 female) were enrolled. The study was terminated prematurely due to withdrawal of financial support by the sponsor. 8 subjects were eligible for the primary analysis, whereas 4 patients were in a predefined exploratory “slow-growing” cohort. In the “fast-growing” cohort, 3 of the 8 patients (37.5%) eligible for first-stage analysis were deemed “success” by the preplanned criteria, adequate to proceed to second-stage accrual. In addition, 1 of the 4 patients in the “slow-growing” cohort experienced a partial remission. Grade 1-2 diarrhea was the most common adverse event, and grade 3 events were infrequent. Conclusion. This study illustrates a novel method of demonstrating positive drug activity in osteosarcoma by increasing tumor doubling time, and this is further supported by a partial response in a patient with “slow-growing” disease. This trial is registered with NCT01759303.
AAPM Task Group Report 272: Comprehensive acceptance testing and evaluation of fluoroscopy imaging systems
Goode, Allen R. , Corwin, Frank, Fisher, Ryan , Balter, Stephen , Wunderle, Kevin , Schueler, Beth A. , Kim, Don‐Soo , Zhou, Yifang , Jenkins, Peter , Mahmood, Usman , Lin, Teh, Zhao, Hui , Park, Mi‐Ae , Trianni, Annalisa , Lendle, Markus, Kuhls‐Gilcrist, Andrew, Jans, J. C., Desponds, L. , Banasiak, Gene, Backes, Steve, Snyder, Angela, Lu, Minghui , Gonzalez, Scott, Lin, Pei‐Jan Paul , Zhang, Jie , Jenkins, Peter A., Snyder, Carl

Mayo Clinic

Medical Physics | January 15, 2022 | Volume: 49 | Issue: 4 | Pages: No page available

10.1002/mp.15429 | PMID 35032394 Get It

AbstractModern fluoroscopes used for image guidance have become quite complex. Adding to this complexity are the many regulatory and accreditation requirements that must be fulfilled during acceptance testing of a new unit. Further, some of these acceptance tests have pass/fail criteria, whereas others do not, making acceptance testing a subjective and time‐consuming task. The AAPM Task Group 272 Report spells out the details of tests that are required and gives visibility to some of the tests that while not yet required are recommended as good practice. The organization of the report begins with the most complicated fluoroscopes used in interventional radiology or cardiology and continues with general fluoroscopy and mobile C‐arms. Finally, the appendices of the report provide useful information, an example report form and topics that needed their own section due to the level of detail.
Two distinct stem cell‐like subtypes of hepatocellular carcinoma with clinical significance and their therapeutic potentials
Lee, Sung Hwan , Jeong, Yun Seong , Sohn, Bo Hwa, Hwang, Ho Kyoung , Choi, Gi Hong , Kang, Chang Moo , Choi, Jin Sub , Lee, Woo Jung , Cheong, Jae‐Ho , Jang, Hee Jin, Roberts, Lewis R. , Yim, Sun Young , Chun, Yun Shin , Roberts, Lewis, Roberts, Lewis R , Kang, Chang Moo , Cheong, Jae-Ho , Lee, Sunyoung , Kaseb, Ahmed O , Lee, Ju‐Seog

Mayo Clinic

Cancer Communications | January 15, 2022 | Volume: 42 | Issue: 2 | Pages: 179-183

10.1002/cac2.12251 | PMID 35032367 Get It

CASPR2‐IgG‐associated autoimmune seizures
Sanabria, E , Zahid, Anza , Kraus, Gregory J., López‐Chiriboga, A. Sebastian , Ζεκερίδου, Αναστασία , Mills, John R. , Pittock, Sean J. , Dubey, Divyanshu , Garrido Sanabria, Emilio R , Britton, Jeffrey, Lopez-Chiriboga, Alfonso Sebastian, Dubey, Divyanshu , Pittock, S J , Britton, Jeffrey W. , Flanagan, Eoin P. , McKeon, Andrew

Mayo Clinic

Epilepsia | January 15, 2022 | Volume: 63 | Issue: 3 | Pages: 709-722

10.1111/epi.17164 | PMID 35032032 Get It

AbstractObjectiveThis study was undertaken to report clinical presentations and outcomes of CASPR2‐IgG‐associated seizures.MethodsMayo Clinic Neuroimmunology database was queried to identify CASPR2‐IgG‐seropositive (CASPR2‐IgG+) patients evaluated at our institution (2009–2019).ResultsOf the 53 CASPR2‐IgG+ patients (titer ≥ 1:10), 20 had seizures (38%). All seizure patients were male, with median onset age of 68 years. Eighteen (90%) had seizures at initial presentation. One patient was found to have malignancy (colon adenocarcinoma). Two patients had coexisting LGI1‐IgG. Twelve patients had archived sera, which on titration had CASPR2‐IgG titers ≥ 1:100. Fifteen patients (75%) met criteria for autoimmune encephalitis. Patients most commonly presented with focal onset, nonmotor seizures with impaired awareness (n = 14, 70%). Eleven patients also had focal motor and/or sensory seizures as one of the seizure semiologies. The majority of patients (n = 11, 55%) developed generalized tonic–clonic seizures during their disease course. Seizure clusters occurred in 12 patients. In addition to seizures, patients developed cognitive disturbance (n = 16, 80%), episodic emotional lability (n = 13, 65%), paroxysmal dizziness (n = 9, 45%), episodic ataxia (n = 6, 30%), and chronic ataxia (n = 9, 45%). Only three patients (15%) had coexisting peripheral nervous system involvement. Frontotemporal or temporal ictal and/or interictal electroencephalographic abnormalities were present among nine patients, and three had multifocal epileptiform abnormalities. Eight patients (40%) had medial temporal T2/fluid‐attenuated inversion recovery hyperintensity on brain magnetic resonance imaging. Elevated cerebrospinal fluid protein and/or lymphocytic pleocytosis was present in most cases (13/14, 93%). Thirteen patients reached seizure freedom following initiation of antiseizure medication (ASM; n = 4) or a combination of immunotherapy and ASM (n = 9). Median duration of follow‐up was 25 months (range = 2–136 months).SignificanceCASPR2‐IgG evaluation should be considered among older male patients with new onset focal seizures and impaired awareness often occurring in clusters with/without features of encephalitis. Coexisting neurological manifestations, including episodic emotional lability, ataxia, and paroxysmal dizziness, also aid in the diagnosis.
Predicting Risk of Surgery in Patients With Small Bowel Crohn’s Disease Strictures Using Computed Tomography and Magnetic Resonance Enterography
Inoue, Akitoshi , Bartlett, David J. , Shahraki, Narges, Sheedy, Shannon P. , Heiken, Jay P. , Voß, Benjamin, Fidler, Jeff L. , Tootooni, M. Samie , Sır, Mustafa Y. , Baker, Mark E. , Rieder, Florian , Deepak, Parakkal , Bruining, David H. , Voss, Benjamin A, Lightner, A L , Deepak, Parakkal , Fletcher, Joel G , Inoue, Akitoshi , Fidler, Jeff L. , Pasupathy, Kalyan S. , Lightner, Amy L. , Fletcher, Joel G.

Mayo Clinic

Inflammatory Bowel Diseases | January 15, 2022 | Volume: 28 | Issue: 11 | Pages: 1677-1686

10.1093/ibd/izab332 | PMID 35032168 Get It

Abstract Background We aimed to determine if patient symptoms and computed tomography enterography (CTE) and magnetic resonance enterography (MRE) imaging findings can be used to predict near-term risk of surgery in patients with small bowel Crohn’s disease (CD). Methods CD patients with small bowel strictures undergoing serial CTE or MRE were retrospectively identified. Strictures were defined by luminal narrowing, bowel wall thickening, and unequivocal proximal small bowel dilation. Harvey-Bradshaw index (HBI) was recorded. Stricture observations and measurements were performed on baseline CTE or MRE and compared to with prior and subsequent scans. Patients were divided into those who underwent surgery within 2 years and those who did not. LASSO (least absolute shrinkage and selection operator) regression models were trained and validated using 5-fold cross-validation. Results Eighty-five patients (43.7 ± 15.3 years of age at baseline scan, majority male [57.6%]) had 137 small bowel strictures. Surgery was performed in 26 patients within 2 years from baseline CTE or MRE. In univariate analysis of patients with prior exams, development of stricture on the baseline exam was associated with near-term surgery (P = .006). A mathematical model using baseline features predicting surgery within 2 years included an HBI of 5 to 7 (odds ratio [OR], 1.7 × 105; P = .057), an HBI of 8 to 16 (OR, 3.1 × 105; P = .054), anastomotic stricture (OR, 0.002; P = .091), bowel wall thickness (OR, 4.7; P = .064), penetrating behavior (OR, 3.1 × 103; P = .096), and newly developed stricture (OR: 7.2 × 107; P = .062). This model demonstrated sensitivity of 67% and specificity of 73% (area under the curve, 0.62). Conclusions CTE or MRE imaging findings in combination with HBI can potentially predict which patients will require surgery within 2 years.
Outcomes After Heart Transplantation in Patients with Cardiac Sarcoidosis
Doulamis, Ilias P. , Alnsasra, Hilmi , Tzani, Aspasia , Kushwaha, Sudhir S. , Asleh, Rabea , Briasoulis, Αlexandros , Álvarez, Paulino , Kuno, Toshiki , Kampaktsis, Polydoros Ν.

Mayo Clinic

ESC Heart Failure | January 15, 2022 | Volume: 9 | Issue: 2 | Pages: 1167-1174

10.1002/ehf2.13789 | PMID 35032102 Get It

Abstract Background The number of patients with sarcoidosis requiring heart transplantation (HT) is increasing. The aim of this study was to evaluate outcomes of isolated HT in patients with sarcoid cardiomyopathy and compare them to recipients with non-ischaemic restrictive or dilated cardiomyopathy. Methods and results Adult HT recipients were identified in the UNOS Registry between 1990 and 2020. Patients were grouped according to diagnosis. The cumulative incidences for the all-cause mortality and rejection were compared using Fine and Gray model analysis, accounting for re-transplantation as a competing risk. Rejection was evaluated using logistic regression analysis. We also reviewed characteristics and outcomes of all HT recipients with previous diagnosis of sarcoid cardiomyopathy from a single centre. A total of 30 160 HT recipients were included in the present study (n = 239 sarcoidosis, n = 1411 non-ischaemic restrictive cardiomyopathy, and n = 28 510 non-ischaemic dilated cardiomyopathy). During a total of 194 733 patient-years, all-cause mortality at the latest follow-up was not significantly different when comparing sarcoidosis to non-ischaemic dilated cardiomyopathy [adjusted subhazard ratio (aSHR) 1.46, 95% confidence intervals (CIs): 0.9–2.4, P = 0.12] or restrictive cardiomyopathy (aSHR 1.12, 95% CI: 0.65–1.95, P = 0.67). Accordingly, multivariable analysis suggested that 1 year mortality was not significantly different between sarcoidosis and non-ischaemic dilated cardiomyopathy (aSHR 1.56, 95% CI: 0.9–2.7, P = 0.12) or restrictive cardiomyopathy (aSHR 1.15, 95% CI: 0.61–2.18, P = 0.66). No differences were observed regarding 30 day mortality, treated and hospitalized acute rejection, and 30 day death from graft failure after HT. Thirty-day mortality did not improve significantly in more recent HT eras whereas there was a trend towards improved 1 year mortality in the latest HT era (P = 0.06). Data from the single-centre case review showed excellent long-term outcomes with sirolimus-based immunosuppression. Conclusions Short-term and long-term post HT outcomes among patients with sarcoid cardiomyopathy are similar to those with common types of non-ischaemic cardiomyopathy.
Snare tip soft coagulation (STSC) after endoscopic mucosal resection (EMR) of large (> 20 mm) non pedunculated colorectal polyps: a systematic review and meta-analysis
Ramai, Daryl , Kassab, Lena L., Draganov, Peter V. , Othman, Mohamed O. , Kochhar, Gursimran , Chandan, Saurabh , Facciorusso, Antonio , Deliwala, Smit , Mohan, Babu P.

Mayo Clinic

Endoscopy International Open | January 14, 2022 | Volume: 10 | Issue: 01 | Pages: E74-E81

10.1055/a-1635-6112 | PMID 35047337 Get It

Abstract Background and study aims Endoscopic mucosal resection (EMR) of laterally spreading tumors (LSTs) > 20 mm in size can be challenging. Piecemeal EMR of these lesions results in high rates of adenoma recurrence at first surveillance colonoscopy (SC1). Snare tip soft coagulation (STSC) of post resection margins is a safe and effective technique to prevent adenoma recurrence. We conducted a systematic review and meta-analysis to evaluate the effectiveness and safety of this technique. Patients and methods Multiple databases were searched through April 2021 for studies that reported on outcomes of post EMR STSC for LSTs > 20 mm in size. Meta-analysis was performed to determine pooled odds of adenoma recurrence as well as pooled proportion of adverse events including intraprocedural and delayed bleeding as well as intraprocedural perforation events. Results Six studies including two randomized controlled trials (RCT) and four cohort studies with 2122 patients were included in the final analysis. Overall pooled odds of adenoma recurrence at SC1 with post EMR STSC compared to no STSC was 0.27 (95 % 0.18–0.42; I2 = 0 %), P < 0.001. Pooled rate of adenoma recurrence at SC1 in post EMR STSC cohort was 6 %. Rates of intraprocedural bleeding, delayed bleeding and intraprocedural perforation were 10.3 %, 6.5 % and 2 % respectively. Conclusions Our results show that thermal ablation of resection margins with STSC in LSTs > 20 mm is a safe and effective technique in reducing the incidence of adenoma recurrence.